The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,292.00
Bid: 1,288.00
Ask: 1,290.00
Change: -6.00 (-0.46%)
Spread: 2.00 (0.155%)
Open: 1,272.00
High: 1,292.00
Low: 1,272.00
Prev. Close: 1,298.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

19 Apr 2017 07:57

RNS Number : 6907C
Victrex PLC
19 April 2017
 
 

 

 

19 April 2017

Victrex plc

Directorate change

David Hummel to retire as Chief Executive

Jakob Sigurdsson appointed as Chief Executive designate

Victrex plc, an innovative world leader in high performance polymer solutions, today announces that David Hummel has notified the Board of his intention to retire after 24 highly successful years as Chief Executive. The Board is pleased to announce that Jakob Sigurdsson, the former Chief Executive of global polymer manufacturer Promens, who has more than 20 years' experience in diverse multinational companies, will join the Company on 1 September 2017 as Chief Executive-designate, following an extensive search process.

Dave, 59, will retire from the Company on 31 March 2018. He will step down as Chief Executive on 30 September 2017, but to enable an orderly transition he will remain on the Board as an Executive Director, reporting to the Chairman, until Victrex's AGM in February 2018. Jakob will succeed Dave as Chief Executive and join the Board on 1 October 2017.

Under Dave's leadership, Victrex has delivered significant shareholder value. Revenue increased from £31 million in 1995 to over £250 million in 2016, with earnings per share growing at more than 10% CAGR.

Larry Pentz, Chairman of Victrex, said: "Dave has been instrumental in Victrex's success. As Chief Executive for nearly 25 years, he has delivered strong growth, helped us to create new markets, innovate into new applications and led a clear and differentiated strategy. We owe significant thanks to Dave for his immense contribution to Victrex and whilst he will remain on the Board until our 2018 AGM, we wish him well in his eventual retirement."

Jakob Sigurdsson, 53, has more than 20 years' experience in large multinational companies, both listed and private, including with Rohm & Haas (acquired by Dow Chemical) in the US, as Chief Executive of food manufacturer Alfesca in Europe, and as Chief Executive of Promens. His roles have spanned marketing, supply chain, business development, strategy and M&A, with particular emphasis on growth in new or developing markets, both within Rohm & Haas and as a CEO and non-executive director.

During his four year tenure as Chief Executive of Promens between 2011 and 2015, he accelerated the Group's growth strategy in both mature and emerging markets, including Pharmaceutical, Chemical and Automotive, leveraging relationships with key global customers. An IPO was initiated in 2014, following the business returning to profitability, prior to a trade sale to RPC Group. Jakob is currently Chief Executive of VIS, the largest Icelandic insurance and re-insurance company, which is listed on the Icelandic stock exchange.

Larry Pentz added: "I am delighted that Jakob will be joining us as our new Chief Executive. He was the standout candidate for the role and has proven experience in delivering focused growth strategies, particularly for new and emerging markets, or new technologies.

"As we communicated at our recent Capital Markets Day, our Polymer & Parts strategy provides a strong platform for growth and the focus is all about execution. Consequently, with Jakob's track record of making markets and delivering growth, as well as his diverse experience in both private and listed companies, the Board believes this appointment is a strong fit with Victrex and will serve us well."

Jakob Sigurdsson commented: "'I am proud and excited to be appointed Chief Executive of such a highly regarded global company. I look forward to working with the Board and the management team to deliver our strategic priorities and execute on our growth opportunities over the coming years."

 

Dave Hummel added: "It has been a privilege to serve Victrex for so many years. I am transitioning from the Company at a time where it is very well positioned for the next phase of growth, with a clear and differentiated strategy, a highly capable management team and a strong pipeline of opportunities. I have every confidence in Jakob and believe that his diverse experience, his passion and curiosity, financial competence and capability will continue to drive the business forward. "

 

There are no disclosures under paragraph 9.6.13R (1)-(6) of the Listing Rules.

 

This announcement contains inside information.

 

Notes:

Jakob Sigurdsson, 53, is an Icelandic national, married with three children. He holds an MBA from Northwestern University in the US, and a BSc in Chemistry from the University of Iceland. His early career was spent in Iceland at a number of manufacturing businesses, including in paint coatings, before joining Rohm & Haas (prior to it becoming part of Dow Chemical) in 1995 within their marketing function.

 

He progressed through several roles at Rohm & Haas, both in Europe and the US, including as General Manager for the Emulsion business in Europe, prior to the acquisition by Dow in 2009. His role as CEO of Alfesca, a food manufacturer in Europe, included acquiring a competitor and divestments of non-core assets. During his role as Chief Executive of Promens between 2011 and 2015, he accelerated the Group's growth strategy in several mature and emerging markets, including Pharmaceutical, Chemical and Automotive markets.

 

Since 2015, Jakob has held a number of non-executive roles in Iceland. He is currently Chief Executive of VIS, the largest Icelandic insurance and re-insurance company, which is listed on the Icelandic stock exchange. Mr Sigurdsson's base salary will be £500,000 and he will participate in the company's bonus and long-term incentive arrangements in accordance with the company's remuneration policy. His notice period of 12 months is in line with other Executive directors. He will relocate to the UK as part of his appointment.

 

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Larry Pentz, Chairman +44 (0) 1253 898150

David Hummel, Chief Executive +44 (0) 1253 898150

Louisa Burdett, Group Finance Director +44 (0) 1253 898150

 

Teneo Blue Rubicon:

Charles Armitstead +44 (0) 7703 330269

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are moving beyond the polymer into semi-finished and finished products ('parts') which shape future performance for our customers and our markets, and drive value for our shareholders. Find out more at www.victrexplc.com

 

 

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 09.00am BST, hosted by Victrex Chairman Larry Pentz. Dial in details: +44 (0) 203 139 4830, participant passcode 61240146#

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAKLNFSSXEEF
Date   Source Headline
7th May 20243:25 pmRNSDirector Declaration
30th Apr 20242:54 pmRNSTotal Voting Rights
28th Mar 20249:56 amRNSTotal Voting Rights
15th Mar 20248:30 amRNSDirectorate Change
6th Mar 20242:06 pmRNSDirector/PDMR Shareholding
29th Feb 20249:36 amRNSTotal Voting Rights
21st Feb 20248:00 amRNSBlock listing Interim Review
9th Feb 202412:16 pmRNSResult of AGM
9th Feb 20247:00 amRNSAGM & Q1 Interim Management Statement
31st Jan 202412:26 pmRNSTotal Voting Rights
25th Jan 202410:57 amRNSHolding(s) in Company
9th Jan 202412:13 pmRNSAnnual Report & Accounts
29th Dec 20239:00 amRNSTotal Voting Rights
12th Dec 202310:21 amRNSDirector/PDMR Shareholding
5th Dec 20232:42 pmRNSDirector/PDMR Shareholding
5th Dec 20232:33 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSVictrex plc - Preliminary Results 2023
1st Dec 202310:41 amRNSBlock listing Interim Review
30th Nov 202311:10 amRNSTotal Voting Rights
3rd Nov 20231:31 pmRNSHolding(s) in Company
31st Oct 20239:36 amRNSTotal Voting Rights
19th Sep 20231:59 pmRNSDirector/PDMR Shareholding
8th Sep 20239:32 amRNSHolding(s) in Company
31st Aug 20239:30 amRNSTotal Voting Rights
23rd Aug 202310:52 amRNSHolding(s) in Company
17th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20239:39 amRNSTotal Voting Rights
18th Jul 202311:51 amRNSDirector/PDMR Shareholding
13th Jul 20232:00 pmRNSAdditional Listing
6th Jul 20237:00 amRNSVictrex plc - Q3 Interim Management Statement
3rd Jul 20234:03 pmRNSHolding(s) in Company
30th Jun 20239:37 amRNSTotal Voting Rights
27th Jun 202310:08 amRNSDirector/PDMR Shareholding
19th Jun 20232:27 pmRNSDirector/PDMR Shareholding
14th Jun 20237:00 amRNSTrading Statement
1st Jun 202312:08 pmRNSBlock listing Interim Review
31st May 20239:52 amRNSTotal Voting Rights
17th May 202310:55 amRNSDirector/PDMR Shareholding
16th May 202310:03 amRNSDirector/PDMR Shareholding
12th May 202310:37 amRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
10th May 20231:34 pmRNSDirector/PDMR Shareholding
9th May 20237:00 amRNSVictrex plc - Interim Results 2023
28th Apr 20239:33 amRNSTotal Voting Rights
18th Apr 20232:00 pmRNSHolding(s) in Company
18th Apr 202310:50 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSDirectorate Change
31st Mar 202310:52 amRNSTotal Voting Rights
20th Mar 20233:07 pmRNSHolding(s) in Company
20th Mar 202310:15 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.